Spectral Precise Image Study for Coronary Artery

ConditionCardiac
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global

About this trial

This is a single-center, comparative, observational, retrospective data study. Datasets from patients who underwent spectral coronary CT angiography (CCTA) for suspected coronary artery disease (CAD) or other diagnosis needs as part of their routine clinical evaluation will be included.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Datasets from Patients who underwent spectral coronary CT angiography (CCTA).

Datasets from study participants with age ≥ 18 years old.

Scan parameters that meet the criteria defined in the 5.4.3.

Disqualifiers

The clinical data information is considered incomplete after evaluation by the investigator.

The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis.

Data of patients deemed inappropriate for inclusion after evaluation by the investigator.

Trial population

Patients completed CCTA scan aged 18.

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • Non-Interventional Study

    Device

    This is an observational study

  • Non-Interventional Study

    Device

    This is an observational study

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Group B1 intervention
Group B: Group A1 intervention

Trial outcomes

Primary outcomes

1

Subjective Image quality using 5 Liket-scale (1-5)

The subjective image quality will be assessed by 2 radiologists using Liket-scale on a range from 1(poor) to 5(Excellent).

Time frame
From date of image reconstruction until the date of image reading completion, anticipated 3Months.

Secondary outcomes

1

Objective image quality

The objective image quality will be evaluated by measuring the CT value shown in the image.

Time frame
From the date of image reconstruction completion to the date of image reading completion, anticipated up to 3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Philips Clinical & Medical Affairs Global

Lead sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: